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Abstract
Background: Stryphnodendron adstringens (Mart.) Coville, Leguminosae, also known in Brazil as
barbatimão, is rich in tannins and many flavan-3-ols and proanthocyanidins such as prodelphinidins
and prorobinetinidins. Previous studies have demonstrated several pharmacological properties of
tannins from barbatimão, including anti-candidal activity.
Methods: The antifungal activity of proanthocyanidin polymeric tannins from Stryphnodendron
adstringens (subfraction F2.4) was evaluated against three strains of Cryptococcus neoformans with
different capsule expressions, using the broth microdilution technique, light microscopy and
transmission electron microscopy. The effect of subfraction F2.4 on C. neoformans and melanoma
mammalian cells pigmentation was also evaluated.
Results: Although susceptibility assays revealed MIC values quite similar (between 2.5 and 5.0 μg/
ml), analyses of MFC values revealing that the acapsular mutant Cap 67 was more susceptible to be
killed by the subfraction F2.4 (MFC = 20 μg/ml) than the two tested capsular strains (T1-444 and
ATCC 28957) (MFC > 160 μg/ml). Optical and electron microscopy experiments revealed relevant
alterations in cell shape and size in all strains treated with 1 and 2.5 μg/ml of subfraction F2.4.
Capsule size of the capsular strains decreased drastically after subfraction F2.4 treatment. In
addition, ultrastructural alterations such as cell wall disruption, cytoplasm extraction, mitochondria
swelling, increase in the number of cytoplasmic vacuoles and formation of membranous structures
in the cytoplasm were also observed in treated yeasts. Incubation with subfraction F2.4 also
decreased  C. neoformans pigmentation, however, did not interfere in melanization of B16F10
mammalian cells.
Conclusion: Our data indicate that tannins extracted from S. adstringens interfered with growth,
capsule size and pigmentation, all important virulence factors of C. neoformans, and may be
considered as a putative candidate for the development of new antifungal agents.
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Background
Stryphnodendron adstringens (Mart.) Coville, Leguminosae,
also known in Brazil as barbatimão, is used in the form of
a decoction or infusion as an adstringent, anti-diarrhoeal,
antimicrobial and hypoglycaemic agent for the treatment
of gynaecological problems and healing wounds [1]. The
stem bark of barbatimão is rich in tannins (10-37%) [2],
many flavan-3-ols and proanthocyanidins such as prodel-
phinidins and prorobinetinidins [3,4]. Previous studies
have demonstrated cicatrizing properties [5], analgesic
and anti-inflammatory activity [6,7] and gastric anti-
ulcerogenic effects [8] of the tannins extracted from the
stem bark of barbatimão.
Also the anti-protozoal effect of tannins from barbatimão
has been described against Herpetomonas samuelpessoai [9],
Trypanosoma cruzi and Leishmania amazonensis [10,11] and
antiviral activity against bovine herpesvirus and poliovi-
rus were also demonstrated by Felipe et al. [12]. In addi-
tion, our group showed a high antifungal activity of a
polymeric tannin (hexameric compound), composed of
monomeric units of prodelphinidins and prorobinetini-
dins, from the stem bark of barbatimão, against clinical
isolates of Candida albicans [13].
Cryptococcus neoformans is an encapsulate opportunistic
yeast that can cause cryptococcosis, predominantly in
immunocompromised patients with underlying predis-
posing factors, such as organ transplantation, haemato-
logical malignancies and advanced human
immunodeficiency virus diseases [14]. This yeast is ubiq-
uitous in the environment and is acquired by inhalation
of desiccated particles, causing pulmonary cryptococcosis
that may be accompanied by systemic dissemination and
it usually manifests itself as meningoencephalitis [14].
The choice of treatment for cryptococcosis depends on the
anatomic sites of involvement and the host's immune sta-
tus. Treatment is usually based on amphotericin B therapy
with or without flucytosine and azole agents. Fluconazole
and itraconazole are the drugs of choice for prophylaxis
and maintenance therapy [15]. Although resistance to
antifungal drugs is rare in C. neoformans, long-term sup-
pressive regimens are raising concern about the develop-
ment of drug resistance [16]. In addition to the limited
number of available therapeutic options to treat crypto-
coccal infections, prolonged therapy may increase the
toxic effects of these drugs on the patient.
C. neoformans is unique among pathogenic fungi in hav-
ing a polysaccharide capsule, mainly composed of glu-
curonoxylomannan (GXM) and galactoxylomannan
(GalXM), which is considered the major contributor to its
virulence. GXM and GalXM units can be released during
cryptococcal infection with deleterious effects to the host
immune response, such as anti-phagocytic and immuno-
suppressive capacity [17].
Melanin synthesis during infection is also considered an
important factor in the virulence of Cryptococcus. Melanin
protects from oxygen and nitrogen oxidants, microbicidal
peptide activity, ingestion and killing by macrophages. In
addition, melanized C. neoformans are less susceptible to
antifungal agents [18].
Drugs interfering in the growth and virulence factors of C.
neoformans can be considered stronger candidates for the
study and development of new antifungal agents. The aim
of this study was to evaluate the antifungal activity of the
polymeric tannin (hexameric compound) extracted from
stem bark of S. adstringens against C. neoformans strains
and to observe its effect on cell growth, morphology,
ultrastructure, capsule size and pigmentation.
Methods
Extraction and characterization of subfraction F2.4 from 
S. adstringens
The stem bark of S. adstringens was collected, dried and
powdered. The crude extract, fractions and subfractions
(including F2.4) were obtained as described by Ishida et
al. [13]. Briefly, the crude extract was obtained by turbo-
extraction (Skymsen) of 100 g of the bark with 70% ace-
tone in water for 20 min. The organic solvent was elimi-
nated by reduced pressure and lyophilized to yield a crude
extract (F1). Next, the F1 (36 g) was suspended in water
(360 mL) and partitioned with ethyl acetate (360 mL) to
obtain a water fraction (F2) and an ethyl acetate fraction
(F3). The F2 fraction (2 g) was chromatographed on a
Sephadex_LH-20 column (h = 170 mm; j = 21 mm, Phar-
macia), using one sequence of eluent system of volumet-
ric proportions with water (50% ethanol, 70% ethanol,
90% ethanol and 70% acetone), obtaining four subfrac-
tions. Chemical characterization of subfraction F2.4 was
analysed by mass spectrometry ES-MS and 13C NMR spec-
troscopy and characterized as a proanthocyanidin poly-
mer (a hexameric compound), composed of
prodelphinidin and prorobinetinidin units and gallic-
acid residues, with an average molecular weight of 2,114
Da. For the experiments realized in this work, the subfrac-
tion F2.4 lyophilized powder (maintained at -20°C
freezer) was diluted directly in RPMI 1640 medium.
Microorganisms
Strains of C. neoformans with different capsular expres-
sions were used in this study. C. neoformans T1-444 (sero-
type A, capsular size around 2.85 μm) is a clinical isolate
from a patient with meningoencephalitis and AIDS, pro-
vided by the Hospital of São Paulo Federal University. The
other two strains (ATCC 28957 - isolated from human
bone lesion - capsular size around 2.66 μm) and Cap 67
acapsular mutant [19] were purchased from the American
Type Culture Collection (ATCC). Cap 67 acapsular
mutant is deposited in the American Type Culture Collec-
tion as ATCC 52817. Stock cultures were maintained onAnnals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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Sabouraud dextrose agar, at 4°C. Subcultures were made
for each experiment in the same medium, at 35°C, for 72
h.
Culture cells
B16F10 murine melanoma cells were kindly provided by
Dr. J. Morgado-Díaz (Instituto Nacional de Cancer,
Divisão de Biologia Celular, Rio de Janeiro/Brazil) and
maintained in RPMI 1640 medium (Gibco Invitrogen
Corporation, New York, USA), supplemented with 2 mM
L-glutamine and heat-inactivated 10% foetal bovine
serum, buffered with sodium bicarbonate and 50 μg/ml
gentamicin. The cultures were maintained at 37°C, in 5%
CO2.
Anti-cryptococcal activity of subfraction F2.4
Minimum inhibitory concentration (MIC) determination
was performed as described in document M27-A3 [20].
Briefly, a two-fold serial dilution of subfraction F2.4 in
RPMI 1640 medium without sodium bicarbonate (Sigma
Chemical Co., MO, USA) buffered with 0.165 M MOPS
(Sigma Chemical Co., MO, USA) was made in 96-well
microtitre trays, to obtain concentrations of 0.31 to 160
μg/ml. A suspension of C. neoformans of 1-5 × 106 cfu/ml
was prepared, diluted 1:1000 and 100 μl was dispensed
into each well containing 100 μl of medium to obtain a
final concentration of 0.5-2.5 × 103 cfu/ml. The microtitre
trays were incubated at 35°C for 72 h in a humid cham-
ber. The MIC values were considered to be the lowest con-
centration that visibly inhibited cryptococcal growth.
Fluconazole (Pfizer, São Paulo, Brazil), itraconazole
(Sigma Chemical Co., MO, USA), and amphotericin B
(Sigma Chemical Co., MO, USA) were used as standard
antifungal.
Minimum fungicidal concentration (MFC) was deter-
mined using an aliquot of 10 μl of the yeast suspension
treated with inhibitory concentrations of subfraction F2.4
and subcultured on a drug-free Sabouraud dextrose agar,
incubated at 35°C, for 72 h. The MFC was determined as
the lowest concentration that showed negative culture
[13].
Light microscopy
Strains of C. neoformans were treated with 1 and 2.5 μg/ml
of subfraction F2.4 in RPMI 1640 medium buffered with
0.165 M MOPS, for 72 h, at 35°C. The yeasts were col-
lected, washed in PBS, pH 7.2 and negatively stained with
India ink. The images were observed by differential inter-
ference contrast (DIC) microscopy with an Axioplan 2
(Zeiss, Germany) optical microscope, acquired using a
Color View SX digital camera and processed with the pro-
gram analysis (Soft Image System, Germany). Morpholog-
ical alterations and budding cells were counted in at least
300 yeasts. The cell and capsule size were measured by the
SemAfore 5.0 program (Jeol, Japan).
Transmission electron microscopy
Strains of C. neoformans were treated with 1 and 2.5 μg/ml
of subfraction F2.4 for 72 h, at 35°C. The yeasts were col-
lected, washed in PBS, pH 7.2 and then fixed in 2.5% glu-
taraldehyde and 4% paraformaldehyde, in 0.1 M
cacodylate buffer. They were then post-fixed in 1%
osmium tetroxide in cacodylate buffer containing 1.25%
potassium ferrocyanide and 5 mM CaCl2 for 2 h, serially
dehydrated in ethanol and embedded in Spurr epoxy
resin. Ultrathin sections were obtained on a Reichert
Ultracut, stained with 5% uranyl acetate and 0.5% lead
citrate and observed in a Zeiss CEM-900 electron micro-
scope.
Effect of subfraction F2.4 on cryptococcal pigmentation
Minimum agar medium (15 mM dextrose, 10 mM
MgSO4, 29.4 mM KH2PO4, 13 mM glycine, 3 μM thia-
mine-HCl and 2% agar) supplemented with 1 mM L-3,4-
dihydroxyphenylalanine (L-dopa, Sigma Chemical Co.,
MO, USA) was used to induce melanization of C. neofor-
mans. Subfraction F2.4 was diluted in minimum agar
medium to obtain concentrations of 5 to 100 μg/ml. An
aliquot of 20 μL of 1 × 106 cfu/ml of the C. neoformans sus-
pension was dispensed on the medium and then incu-
bated in a dark humid chamber for 5 days, at 35°C.
Medium without L-dopa was used as a negative control
for melanin synthesis. Medium - without yeast - supple-
mented with L-dopa was used to observe if autopolymer-
ization occurred.
The images were obtained using a transilluminator and a
digital camera without flash illumination. The colony pig-
mentation was measured using the program Image J,
developed by the National Institutes of Health (NIH,
USA) http://rsb.info.nih.gov/ij/. The percentage of pig-
mentation inhibition was calculated by comparison with
the positive control for cryptococcal pigmentation.
Effect of subfraction F2.4 on B16F10 cell melanogenesis
A B16F10 cell suspension of 2.5 × 105 cell/ml was dispensed
into each well of 6-well microplates, for 24 h, to allow the
cells to adhere. Subsequently, the cells were treated with
several concentrations of subfraction F2.4 (1, 10, 50, and
100 μg/ml) for 48 h, at 37°C and 5% CO2. The cell mon-
olayers were resuspended in PBS, pH 7.2, and counted in
a haemocytometer chamber. Cell suspension was treated
with 1 N NaOH for 24 h, at 37°C, for melanin extraction.
Absorbance was determined in a spectrophotometer
(Model UV-1700-Pharmaspec, Shimadzu, Japan) at 475
nm wavelength. Melanin concentration was determined
using a standard curve for synthetic melanin (Sigma
Chemical Co., MO, USA). Synthetic melanin standard
curve was constructed using 0.78, 1.56, 3.12, 6.25, 12.5,
25 and 50 μg/ml of melanin diluted in 1 N NaOH and the
absorbance at 475 nm wavelength of each concentration
was obtained with a quartz cuvette containing 1 ml ofAnnals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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each solution. Background of the each concentration was
subtracted using absorbance the 1 N NaOH solution. The
melanin standard curve presented a linear profile (R2 =
0.9999). Than, melanin concentration per 105 cells was
calculated.
Statistical analysis
The results were analyzed using the Prism 5.0 computer
program. The data obtained in experimental models were
evaluated by one-way analysis of variance (ANOVA) fol-
lowed by Dunnett's test. Differences between the control
raw mean and the drug groups raw means were consid-
ered to be statistically significant when p < 0.05.
Results
Anti-cryptococcal activity of polymeric tannin from S. 
adstringens
The MICs of subfraction F2.4 were 2.5 and 5 μg/ml to
acapsular and capsular strains, respectively (Table 1).
Additionally, sub-inhibitory concentrations, 1 and 2.5 μg/
ml, of subfraction F2.4 inhibited the growth of ATCC
28957 strain by 16.67% and 36.67%, respectively and of
Cap 67 strain by 56.87% and 86.87%; but did not inhibit
the growth of T1-444 strain. Although the acapsular strain
Cap 67 had shown similar susceptible to subfraction F2.4
as the T1-444 and ATCC 28957 strains, the MFC values of
Cap 67 were at least 8 times lower when compared to the
MFC values of the capsular strains (Table 1). T1-444,
ATCC 28954 and Cap 67 strains were all susceptible to
fluconazole, itraconazole and amphotericin B. We did not
find any relevant differences between the MIC or MFC val-
ues of the three tested strains in relation to fluconazole,
itraconazole and amphotericin B (Table 1).
Light microscopy
In order to examine the effect of subfraction F2.4 on the
morphology of capsular (ATCC 28954 and T1-444) and
acapsular (CAP 67) strains of C. neoformans, the yeasts
were cultivated or not (control cells) in the presence of the
drug and examined by light microscopy. Control capsular
cells showed a regular oval cell shape and are homogene-
ously surrounded by the polysaccharide capsule (Figs. 1A
and 1F). The treatment of the strains with 1 and 2.5 μg/ml
of subfraction F2.4 lead to a significant reduction in cap-
sule size (Figs. 1E and 1J) and decrease of cell size when
compared with the control cells (Figs. 1E and 1J).
Treatment of these yeasts with subfraction F2.4 also leads
to several morphological alterations such as: (i) the non
separation of young bud cells (Figs. 1B-C and 1G-H); (ii)
elongation of the young buds (Fig. 1H); and (iii) appear-
ance of smaller and anamorphous yeasts (Figs. 1D and
1I). The capsular strains of C. neoformans did not show any
significant differences in the counting of the yeast bud-
ding.
The untreated yeasts of C. neoformans Cap 67 showed
agglomerate yeasts characteristic of this strain (Fig. 1K).
For this reason, it was not possible to count the yeast
buds. No significant alteration in cell size was observed.
However, we observed many changes in yeast morphol-
ogy such as the appearance of decreasing moon (Fig. 1M)
and of globular cells (Fig. 1N) after incubation with sub-
fraction F2.4.
Transmission electron microscopy
Untreated yeasts had a compact cell wall (cw), capsule (c)
and a cytoplasm with a regular electron density and many
ribosomes (Fig. 2A). Ultrastructural analyses of C. neofor-
mans ATCC 28957 revealed several morphological altera-
tions after treatment with subfraction F2.4 (Figs. 2B-F).
Yeast of C. neoformans ATCC 28957 treated with 1 μg/ml
of the subfraction F2.4 showed disruption of the cell wall
(arrow, in Figs. 2C-D), changes in the yeast morphology
and in the budding process (Figs. 2C-D). The presence of
membranous structures (arrowheads, in Figs. 2B-C), large
vacuoles (v, in Fig. 2D), mitochondria swelling (m, in Fig.
2B) were found in the cytoplasm of the treated yeasts.
Yeasts treated with 2.5 μg/ml of subfraction F2.4 showed
more-drastic alterations with irregular buds emerging
from the lateral of the mother cells instead of from the
usual terminal, complete loss of the normal cellular ovu-
lar shape, cell wall detachment (arrows), membranous
structures (arrowheads) and extracted cytoplasm suggest-
Table 1: Anti-cryptococcal activity of subfraction F2.4 from Stryphnodendron adstringens against strains of Cryptococcus neoformans with 
different capsule expressions: T1-444 strain, ATCC 28957 strain and an acapsular mutant (Cap 67 strain). 
Drugs C. neoformans
T1-444
C. neoformans
ATCC 28957
C. neoformans
Cap67
MIC MFC MIC MFC MIC MFC
Subfraction F2.4 5 >160 5 >160 2.5 20
F l u c o n a z o l e 4 1 6 2828
Itraconazole 0.12 8 0.12 8 0.03 8
Amphotericin B 0.12 0.25 0.06 0.25 0.06 0.12
Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) are in μg/ml.Annals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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Morphological alterations of C. neoformans strains (T1-444, ATCC 28957 and Cap 67 strains) treated with 1 and 2.5 μg/ml of  subfraction F2.4 from S. adstringens Figure 1
Morphological alterations of C. neoformans strains (T1-444, ATCC 28957 and Cap 67 strains) treated with 1 
and 2.5 μg/ml of subfraction F2.4 from S. adstringens. A, F and K: Control; B, G and L: 1 μg/ml; C-D, H-I and M-N: 
2.5 μg/ml; E, J and O: capsule and cell size (μm) of C. neoformans strains untreated and treated with subfraction F2.4. ** p < 
0.01.Annals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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ing cell death (Figs. 2E-F). The T1-444 strain showed sim-
ilar alterations in cellular ultrastructure, however less
pronounced than the ATCC 28957 strain (data not
shown).
Yeasts of the acapsular mutant (Cap 67) presented more
drastic alterations when grown in the presence of 1 μg/ml
(Figs. 3B-D) or 2.5 μg/ml (Figs. 3E-F) of subfraction F2.4.
The ultrastructure of untreated yeasts was preserved, with
compact cell wall (cw), nucleus (n), nucleolus (nu), mito-
chondria (m) and electron-dense glycogen granules (Fig.
3A). In contrast, treated yeasts showed many ultrastruc-
tural alterations such as budding of vesicular bodies into
vacuoles lumen (Fig. 3C, white asterisk), cell wall disas-
sembling (arrows in Figs. 3D-E), an increase in number
and in size of electron lucent vacuoles (v) (Figs. 3B-C and
3F) and intracellular membranous structures (arrowheads
in Figs. 3E-F). These membranous structures were also
observed inside the vacuoles (arrowheads in Fig. 3C).
Polymeric tannin reduce cryptococcal pigmentation
C. neoformans treated with subfraction F2.4 grown in min-
imum agar medium supplemented with 1 mM L-dopa
were significantly less pigmented than the control cells
(Fig. 4). The hexameric condensed tannin was more active
to inhibit the pigmentation of the acapsular strain Cap 67
than the capsular strains. Pigmentation was strongly
reduced in Cap 67 at concentrations of 10-100 μg/ml
Transmission electron micrographs of C. neoformans ATCC  28957 strain grown in the presence of subfraction F2.4 from  S. adstringens for 72 h, at 35°C Figure 2
Transmission electron micrographs of C. neoformans 
ATCC 28957 strain grown in the presence of subfrac-
tion F2.4 from S. adstringens for 72 h, at 35°C. 
Untreated yeasts have a compact cell wall (cw) surrounded 
by a polysaccharide capsule (c) (A); Yeasts treated with 1 
μg/ml (B-D) and 2.5 μg/ml (E-F) show several ultrastruc-
tural alterations, such as cell-wall disruption (black arrow), 
presence of vacuoles (v) mitochondrial swelling (m) and 
many membranous structures in the cytoplasm (black arrow-
head). Bars = 1 μm.
Transmission electron micrographs of acapsular mutant Cap  67 grown in the presence of subfraction F2.4 from S. adstrin- gens for 72 h, at 35°C Figure 3
Transmission electron micrographs of acapsular 
mutant Cap 67 grown in the presence of subfraction 
F2.4 from S. adstringens for 72 h, at 35°C. Untreated 
yeasts have a compact cell wall (cw), nucleus (n), nucleolus 
(nu), mitochondria (m) and many electron-dense granules 
(glycogen) (A). Yeasts treated with 1 μg/ml (B-D) and 2.5 
μg/ml (E-F) showed drastic ultrastructural alterations. Dis-
ruption of cell wall (black arrow), membranous structures 
(black arrowhead and details in the box of Fig. E and F), vacu-
oles (v) and budding of vesicular bodies in the vacuole lumen 
(white asterisk) can be observed. Bars = 1 μm.Annals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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(39.25-56.9%, p < 0.01), however in ATCC 28957 it was
significantly reduced only in 100 μg/ml of subfraction
F2.4 (35.1%, p < 0.01). The polymeric tannin did not
affect T1-444 strain pigmentation at concentrations ≤100
μg/ml.
Effect of the polymeric tannin on melanogenesis of B16F10 
cells
The effect of subfraction F2.4 on mammalian cell (B16F10)
melanogenesis was also evaluated. Concentrations ≤100
μg/ml of subfraction F2.4 did not alter melanin synthesis
in B16F10 cells (p > 0.05) (data not shown).
Discussion
The small number of commercial antifungal agents, the
inappropriate pharmacokinetics and the toxic effects are
important factors related to unsuccessful treatments of
cryptococcosis and other mycosis. Consequently there is
an increasing need for new compounds with antifungal
activity. Natural products, including plants, may be a
source of compounds with antifungal effects and there-
fore possible candidates for the development of new anti-
fungal agents [21,22].
In this study, we observed the activity of subfraction F2.4
(a hexameric compound) extracted from the stem bark of
barbatimão, against three strains of C. neoformans with
different capsule expressions. The acapsular mutant Cap
67 was more susceptible than the capsular strains;
although only small differences were observed between
MIC values of the three strains the MFC results for the cap-
sulate strains was at least 8 times higher than for the acap-
sular one. These data suggest that the presence of a capsule
surrounding C. neoformans cells may influence the anti-
cryptococcal activity of the hexameric compound (Table
1). Interestingly, the presence of a capsule did not inter-
fere with the action of fluconazole, itraconazole or
amphotericin B.
Yeasts treated with sub-inhibitory concentrations of sub-
fraction F2.4 showed changes in cell morphology and also
their cell size and capsule size decreased significantly
when compared to untreated yeasts. The treatment with
hexameric compound may interfere with the uptake of
nutrients important for normal fungal development.
Several ultrastructural alterations of C. neoformans treated
with subfraction F2.4 were observed including the pres-
ence of yeasts with altered shape, an amorphous material
shading from the cell wall, an increase in the size of vacu-
oles, appearance of membranous structures and mito-
chondria swelling. Similar mitochondrial alterations were
previously reported by Holetz et al. after treatment of pro-
tozoan by tannins [9]. These authors suggested the
involvement of the tannins in the oxidative phosphoryla-
tion and electron transport defects. Interestingly, yeasts of
the acapsular mutant C. neoformans Cap 67 showed more
drastic ultrastructural alterations than the other strains.
The formation and budding of vesicles in the vacuoles
lumen can be characterized as autophagic bodies, suggest-
ing death of C. neoformans by autophagy [23]. In addition,
the structures of concentric membranes are similar to
myelin-like figures, which are also related to an
autophagic process [24]. These structures were more fre-
quently observed in the treated Cap 67 strain. Although
autophagy is a cell mechanism that is necessary for the
survival and pathogenesis of many fungi, including C.
neoformans [25,26], it is also a mechanism of fungal death
induced by antifungal drugs [27-29].
In a previous study, we demonstrated antifungal activity
of subfraction F2.4 extracted from barbatimão against C.
albicans isolates [13]. We observed growth inhibition and
alteration of the cell wall of C. albicans, which may be
related to a change in cell surface hydrophobicity,
decrease in the capacity of adherence to eukaryotic cells
and glass surfaces, inhibition of germ-tube formation and
stimulus of phagocytosis by macrophages. The anti-candi-
dal activity was related to the polymeric tannin present in
subfraction F2.4 (hexameric compound), which is com-
posed of monomeric units of proanthocyanidins (prodel-
phinidins and prorobinetinidins) and gallic-acid residues.
A wide range of antimicrobial activity (against filamen-
tous fungi, yeasts and bacteria), stimulation of phagocyte
Pigmentation percentage of C. neoformans strains treated  with several concentrations of the subfraction F.24 (5 to 100  μg/ml) in minimum medium supplemented with 1 mM L-dopa Figure 4
Pigmentation percentage of C. neoformans strains 
treated with several concentrations of the subfrac-
tion F.24 (5 to 100 μg/ml) in minimum medium sup-
plemented with 1 mM L-dopa. Subfraction F2.4 from S. 
adstringens reduced the pigmentation of C. neoformans with 
different capsule expressions. **p < 0.01; *** p < 0.001.Annals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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cells and host-mediated tumour activity have been
assigned to tannins [30]. Polyphenols may precipitate
and/or complex with a variety of macromolecules, includ-
ing polysaccharides, proteins, alkaloids, polymers and
cyclodextrins [31]. They appear to associate with macro-
molecules through non-specific forces such as hydrogen
bonding to H-bond-accepting groups and hydrophobic
interactions arising from the aromatic rings in their gallic
acids, as well as by covalent-bond formation [31]. The
increase in tannin polymerisation also increases the
degree of intermolecular reaction [32]. In addition, the
number of hydroxyl groups on the B-ring affects the level
of growth inhibition of many microorganisms [33], sug-
gesting that the trihydroxylated B-rings of proanthocyani-
dins may have higher antimicrobial action [13]. Thus, the
antifungal activity of subfraction F2.4 polymeric tannin
against C. neoformans strains may be related to the ability
of tannins to inhibit extracellular microbial enzymes, dep-
rivation of substrates and metal-ion cell-envelope trans-
port proteins and the direct action on microbial
metabolism through inhibition of oxidative phosphoryla-
tion [33].
The capsular compounds GXM and GalXM are synthe-
sized intracellularly, transported to the extracellular space
inside membrane vesicles and then released extracellu-
larly for capsular enlargement. However, it is not clear
how GXM and GalXM fibres are incorporated into the
capsule [34]. It has been suggested that capsular assembly
in C. neoformans results from divalent cation-mediated
self-aggregation of extracellular-accumulated GXM mole-
cules [35]. Interestingly, the hexameric compound of sub-
fraction F2.4 promoted a reduction of the capsule size and
this effect seemed to be dose-dependent. He et al. [36]
showed that hydrogen bonding is the predominant effect
in the interactions between gallotannins and carbohy-
drates. Subfraction F2.4 polymeric tannin could act by
inhibiting the incorporation of capsular components by
hydrogen bonding or divalent-cation scavenging. How-
ever, we observed that anti-cryptococcal activity of sub-
fraction F2.4 previously incubated with the supernatant of
C. neoformans T1-444 strain culture (rich in capsular com-
ponents) was similar to that of subfraction F2.4 alone
(data not shown). Together, these data suggest that the
hexameric compound of subfraction F2.4 is not inhibiting
the incorporation of capsular components but is probably
interfering in other processes, such as the synthesis of cap-
sular compounds and/or the transport of vesicles to the
extracellular moiety.
Melanin is a pigment produced by several pathogenic
fungi and is considered to be an important virulence fac-
tor for C. neoformans [18]. Its synthesis depends on laccase
and also on the presence of exogenous substrates (such as
L-dopa and epinephrine). Laccase is a phenoloxidase
enzyme present in the cell wall that possesses a broad
spectrum of activity, oxidizing polyphenolic compounds.
Although the details of the chemical structure of melanin
are largely unknown, it is believed to be a cross-linked
polymer of phenol and indole subunits that are organized
in many spherical granular particles arranged in multiple
concentric layers in the cell wall [37]. Recently, Rodrigues
et al. [38] demonstrated the secretion of pathogenesis-
related molecules, including a laccase, by trans-cell-wall
transport into membrane vesicles.
Baurin et al. [39] showed that the extract from stem bark
of barbatimão strongly inhibits (close to 90%) Neurospora
crassa  tyrosinase, a phenoloxidase enzyme. We suggest
that the hexameric compound of subfraction F2.4 could
inhibit the synthesis of melanin by inhibiting laccase
enzyme or by inhibiting cross linking of phenol and
indole units. Analyzing the protein alignment of human
tyrosinase (E.C.1.14.18.1) and C. neoformans laccase
(E.C.10.32), both phenoloxidase enzymes, we can
observe low similarity comparing both aminoacid
sequences, using the NCBI BLAST databases at National
Center for Biotechnology Information (NCBI - http://
www.ncbi.nlm.nih.gov) (data not show). These data may
explain the possible selectivity of the hexameric com-
pound for C. neoformans laccase enzyme. In addition,
interference in the nutrient acquisition and changes in the
cell wall morphology caused by the treatment with hexa-
meric compound of subfraction F2.4 could also be inter-
fering with the melanin synthesis and its destination.
Disturbance of the homeostasis of melanin synthesis by
the hexameric compound of subfraction F2.4 could
decrease the virulence and pathogenesis of C. neoformans.
Interestingly, the presence of a capsule in C. neoformans
interferes with the inhibition of pigmentation by subfrac-
tion F2.4. Furthermore, we did not observe interference in
melanin synthesis of B16F10 cells in concentrations ≤100
μg/ml, which may imply a selective action of the poly-
meric tannin from barbatimão on C. neoformans.
The cytotoxic effect of the subfraction F2.4 from S. adstrin-
gens was previously evaluated against mammalian cells
(Vero, macrophage J774G8 and red blood cells) by Ishida
et al [13]. The cytotoxic concentration of 50% (CC50) of
the subfraction F2.4 for those cells was higher than 100
μg/ml [13]. It represented a selective index (SI = CC50/
MIC) to C. neoformans of 33 and 20 to Vero and J774G8
cells, respectively. In addition, no haemolytic effect was
observed in concentrations lower than 1000 μg/ml of the
subfraction F2.4 [13]. In contrast, polyene agents (such as
amphotericin B) show a larger haemolytic pattern when
compared to the crude extract of S. adstringens [11].
Conclusion
In accordance with previous studies reported on C. albi-
cans [13], the hexameric compound extracted from barba-
timão works on C. neoformans as a cytostatic antifungalAnnals of Clinical Microbiology and Antimicrobials 2009, 8:29 http://www.ann-clinmicrob.com/content/8/1/29
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agent. It displays an important biological activity against
C. neoformans interfering with: cellular homeostasis, yeast
growth, polysaccharide capsule formation and fungal pig-
mentation. In addition, the subfraction F2.4 presented
low citotoxicity against mammalian cells [13].
These data together show the potential of the hexameric
compound to start the development of a new antifungal
agent to treat not only cryptococcosis or candidiasis but it
could also be used against other types of mycosis.
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